Viewing Study NCT06433206



Ignite Creation Date: 2024-06-16 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06433206
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2024-05-22

Brief Title: Care Needs in Lung Cancer Patients Receiving Immunotherapy
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Study Overview

Official Title: Quality of Life Symptom Severity and Care Needs in Lung Cancer Patients Receiving Immunotherapy
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Lung cancer ranks as the leading cause of cancer-related deaths globally and is among the most common malignancies In recent years the advancements in immune checkpoint inhibitors have marked a significant breakthrough in the immunotherapy of lung cancer However immunotherapy is a relatively new treatment modality and ongoing clinical trials continue to explore its efficacy Due to a lack of knowledge about immunotherapy-related care patients often experience uncertainty and anxiety regarding its effectiveness resulting in associated care needs

A total of 160 lung cancer patients were included in the study The research findings revealed statistically significant correlations p 005 between the severity of disease symptomatology overall health status functional capacity cognitive function disease progression mood and general supportive care needs as well as specific needs of lung cancer patients

Regarding factors influencing care needs it was found that general supportive care needs were significantly influenced by marital status average personal monthly income and disease progression Additionally age surgical history functional capacity and cognitive function significantly influenced specific care needs Based on these statistical findings it is crucial for nursing staff to closely monitor changes in patients symptoms and mood and provide timely care and support Furthermore future interventions should focus on addressing the heightened needs of lung cancer patients thereby reducing their dissatisfaction along the cancer treatment journey
Detailed Description: Background and Purpose Lung cancer is a major health concern affecting the Taiwanese population Immunotherapy represents a novel treatment approach which activates the immune system to combat tumor cells through a series of interactions However the side effects associated with immunotherapy can be significant potentially causing uncertainty and anxiety in patients Medical decision-making also involves numerous considerations impacting their psychosocial well-being and subsequent health behaviors Research in this area remains limited Therefore this study aims to 1 explore the quality of life severity of symptoms and care needs of lung cancer patients following immunotherapy 2 investigate the correlations between quality of life severity of symptoms and care needs and 3 identify predictive factors for the care needs of immunotherapy patients

Research Method This study adopts a cross-sectional research design conducted at a medical center and a specialized cancer hospital in Taipei City Recruitment takes place in hospital wards treatment rooms and outpatient clinics utilizing consecutive sampling Lung cancer patients who have undergone or are currently undergoing immunotherapy are selected Structured questionnaires are employed covering demographics disease treatment characteristics severity of symptoms quality of life functional disability supportive care needs fear of disease progression and qualitative interviews Quantitative data are analyzed using descriptive and inferential statistics in SPSS version 220 The study aims to enroll 180 participants

Expected Results The anticipated findings of this study are expected to provide valuable insights for clinical healthcare professionals They can aid in understanding patients needs contribute to the development of post-immunotherapy care guidelines for lung cancer patients and serve as essential references for healthcare reimbursement policies These outcomes may help alleviate patient burden and enhance quality of life It is expected that demographic characteristics disease treatment characteristics quality of life severity of symptoms and the extent of care needs will be positively correlated and serve as important predictors of care needs

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None